Priority Date: 10.08.12 (US 201213572263)

PRODUCTION AND UTILIZATION OF A NOVEL ANTI-CANCER DRUG IN THERAPY

  • Application ID: EP13827192
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1884
Headquarter in Birmingham and 5 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 10.08.2012 - Priority Date (US 201213572263)
  • 13.02.2014 - Publication A2 (WO2014026189)
  • 17.06.2015 - Publication A2 (EP2882859)

IPC Classification